Effects of three new anthracyclines and doxorubicin on the rat isolated heart

Min Hen Z Min Hen, T. Colombo, L. Conforti, M. G. Donnelli, J. Fiedorowicz, S. Marchi, A. Paolini, E. Riva, G. Zuanetti, R. Latini

Research output: Contribution to journalArticle

Abstract

The acute cardiac toxicity of three second-generation anthracycline analogues and doxorubicin was compared in a model of the rat isolated Langendorff perfused heart. The drugs, doxorubicin (DX), 4-epi-doxorubicin (4'EDX), 4-demethoxy-daunorubicin (4DMDR) and 4'-deoxy-doxorubicin (4'dxDX) were infused for 40 min at a concentration of 26 μM into the isolated hearts. All four compounds significantly reduced cardiac work and its first derivative. The time to 50% decrease in work (TW50) was respectively 36, 23, 9 and 7 min for DX, 4'EDX, 4'dxDx and 4DMDR. The three anthracycline derivatives, but not DX, significantly increased coronary resistance. Heart rate was reduced by all compounds compared with baseline, but not compared with controls. Rhythm disturbances were seen with all five hearts perfused with 4DMDR, which stopped beating before 40 min; 2/5 hearts in the 4'EDX group and 1/5 hearts in the 4'dxDX group also stopped before the end of perfusion. All the compounds reached concentrations in the myocardium 8 to 50 times higher than in the perfusing medium. The more cardiotoxic the compound, the higher was its myocardial concentration; a significant correlation was found for all four agents. Noradrenaline was never measurable in the perfusate of control and DX hearts; perfusion with the three anthracycline derivatives caused some release, but the pattern was not clearcut and the maximum concentrations attained in the perfusate were relatively low (≤1.6 X 10-9 M). In conclusion, in the rat isolated perfused heart, the early cardiotoxicity induced by equimolar concentrations of the three anthracycline compounds was greater than that induced by DX and was directly related to drug accumulation in the myocardium. Catecholamines do not seem to have a major role in the development of toxicity in this model.

Original languageEnglish
Pages (from-to)947-950
Number of pages4
JournalJournal of Pharmacy and Pharmacology
Volume39
Issue number11
Publication statusPublished - 1987

Fingerprint

Anthracyclines
Doxorubicin
Epirubicin
Daunorubicin
Myocardium
Perfusion
Pharmaceutical Preparations
Catecholamines
Norepinephrine
Heart Rate

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Z Min Hen, M. H., Colombo, T., Conforti, L., Donnelli, M. G., Fiedorowicz, J., Marchi, S., ... Latini, R. (1987). Effects of three new anthracyclines and doxorubicin on the rat isolated heart. Journal of Pharmacy and Pharmacology, 39(11), 947-950.

Effects of three new anthracyclines and doxorubicin on the rat isolated heart. / Z Min Hen, Min Hen; Colombo, T.; Conforti, L.; Donnelli, M. G.; Fiedorowicz, J.; Marchi, S.; Paolini, A.; Riva, E.; Zuanetti, G.; Latini, R.

In: Journal of Pharmacy and Pharmacology, Vol. 39, No. 11, 1987, p. 947-950.

Research output: Contribution to journalArticle

Z Min Hen, MH, Colombo, T, Conforti, L, Donnelli, MG, Fiedorowicz, J, Marchi, S, Paolini, A, Riva, E, Zuanetti, G & Latini, R 1987, 'Effects of three new anthracyclines and doxorubicin on the rat isolated heart', Journal of Pharmacy and Pharmacology, vol. 39, no. 11, pp. 947-950.
Z Min Hen MH, Colombo T, Conforti L, Donnelli MG, Fiedorowicz J, Marchi S et al. Effects of three new anthracyclines and doxorubicin on the rat isolated heart. Journal of Pharmacy and Pharmacology. 1987;39(11):947-950.
Z Min Hen, Min Hen ; Colombo, T. ; Conforti, L. ; Donnelli, M. G. ; Fiedorowicz, J. ; Marchi, S. ; Paolini, A. ; Riva, E. ; Zuanetti, G. ; Latini, R. / Effects of three new anthracyclines and doxorubicin on the rat isolated heart. In: Journal of Pharmacy and Pharmacology. 1987 ; Vol. 39, No. 11. pp. 947-950.
@article{4a47b11dee9c4107a438c293390075ba,
title = "Effects of three new anthracyclines and doxorubicin on the rat isolated heart",
abstract = "The acute cardiac toxicity of three second-generation anthracycline analogues and doxorubicin was compared in a model of the rat isolated Langendorff perfused heart. The drugs, doxorubicin (DX), 4-epi-doxorubicin (4'EDX), 4-demethoxy-daunorubicin (4DMDR) and 4'-deoxy-doxorubicin (4'dxDX) were infused for 40 min at a concentration of 26 μM into the isolated hearts. All four compounds significantly reduced cardiac work and its first derivative. The time to 50{\%} decrease in work (TW50) was respectively 36, 23, 9 and 7 min for DX, 4'EDX, 4'dxDx and 4DMDR. The three anthracycline derivatives, but not DX, significantly increased coronary resistance. Heart rate was reduced by all compounds compared with baseline, but not compared with controls. Rhythm disturbances were seen with all five hearts perfused with 4DMDR, which stopped beating before 40 min; 2/5 hearts in the 4'EDX group and 1/5 hearts in the 4'dxDX group also stopped before the end of perfusion. All the compounds reached concentrations in the myocardium 8 to 50 times higher than in the perfusing medium. The more cardiotoxic the compound, the higher was its myocardial concentration; a significant correlation was found for all four agents. Noradrenaline was never measurable in the perfusate of control and DX hearts; perfusion with the three anthracycline derivatives caused some release, but the pattern was not clearcut and the maximum concentrations attained in the perfusate were relatively low (≤1.6 X 10-9 M). In conclusion, in the rat isolated perfused heart, the early cardiotoxicity induced by equimolar concentrations of the three anthracycline compounds was greater than that induced by DX and was directly related to drug accumulation in the myocardium. Catecholamines do not seem to have a major role in the development of toxicity in this model.",
author = "{Z Min Hen}, {Min Hen} and T. Colombo and L. Conforti and Donnelli, {M. G.} and J. Fiedorowicz and S. Marchi and A. Paolini and E. Riva and G. Zuanetti and R. Latini",
year = "1987",
language = "English",
volume = "39",
pages = "947--950",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "11",

}

TY - JOUR

T1 - Effects of three new anthracyclines and doxorubicin on the rat isolated heart

AU - Z Min Hen, Min Hen

AU - Colombo, T.

AU - Conforti, L.

AU - Donnelli, M. G.

AU - Fiedorowicz, J.

AU - Marchi, S.

AU - Paolini, A.

AU - Riva, E.

AU - Zuanetti, G.

AU - Latini, R.

PY - 1987

Y1 - 1987

N2 - The acute cardiac toxicity of three second-generation anthracycline analogues and doxorubicin was compared in a model of the rat isolated Langendorff perfused heart. The drugs, doxorubicin (DX), 4-epi-doxorubicin (4'EDX), 4-demethoxy-daunorubicin (4DMDR) and 4'-deoxy-doxorubicin (4'dxDX) were infused for 40 min at a concentration of 26 μM into the isolated hearts. All four compounds significantly reduced cardiac work and its first derivative. The time to 50% decrease in work (TW50) was respectively 36, 23, 9 and 7 min for DX, 4'EDX, 4'dxDx and 4DMDR. The three anthracycline derivatives, but not DX, significantly increased coronary resistance. Heart rate was reduced by all compounds compared with baseline, but not compared with controls. Rhythm disturbances were seen with all five hearts perfused with 4DMDR, which stopped beating before 40 min; 2/5 hearts in the 4'EDX group and 1/5 hearts in the 4'dxDX group also stopped before the end of perfusion. All the compounds reached concentrations in the myocardium 8 to 50 times higher than in the perfusing medium. The more cardiotoxic the compound, the higher was its myocardial concentration; a significant correlation was found for all four agents. Noradrenaline was never measurable in the perfusate of control and DX hearts; perfusion with the three anthracycline derivatives caused some release, but the pattern was not clearcut and the maximum concentrations attained in the perfusate were relatively low (≤1.6 X 10-9 M). In conclusion, in the rat isolated perfused heart, the early cardiotoxicity induced by equimolar concentrations of the three anthracycline compounds was greater than that induced by DX and was directly related to drug accumulation in the myocardium. Catecholamines do not seem to have a major role in the development of toxicity in this model.

AB - The acute cardiac toxicity of three second-generation anthracycline analogues and doxorubicin was compared in a model of the rat isolated Langendorff perfused heart. The drugs, doxorubicin (DX), 4-epi-doxorubicin (4'EDX), 4-demethoxy-daunorubicin (4DMDR) and 4'-deoxy-doxorubicin (4'dxDX) were infused for 40 min at a concentration of 26 μM into the isolated hearts. All four compounds significantly reduced cardiac work and its first derivative. The time to 50% decrease in work (TW50) was respectively 36, 23, 9 and 7 min for DX, 4'EDX, 4'dxDx and 4DMDR. The three anthracycline derivatives, but not DX, significantly increased coronary resistance. Heart rate was reduced by all compounds compared with baseline, but not compared with controls. Rhythm disturbances were seen with all five hearts perfused with 4DMDR, which stopped beating before 40 min; 2/5 hearts in the 4'EDX group and 1/5 hearts in the 4'dxDX group also stopped before the end of perfusion. All the compounds reached concentrations in the myocardium 8 to 50 times higher than in the perfusing medium. The more cardiotoxic the compound, the higher was its myocardial concentration; a significant correlation was found for all four agents. Noradrenaline was never measurable in the perfusate of control and DX hearts; perfusion with the three anthracycline derivatives caused some release, but the pattern was not clearcut and the maximum concentrations attained in the perfusate were relatively low (≤1.6 X 10-9 M). In conclusion, in the rat isolated perfused heart, the early cardiotoxicity induced by equimolar concentrations of the three anthracycline compounds was greater than that induced by DX and was directly related to drug accumulation in the myocardium. Catecholamines do not seem to have a major role in the development of toxicity in this model.

UR - http://www.scopus.com/inward/record.url?scp=0023603433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023603433&partnerID=8YFLogxK

M3 - Article

C2 - 2892924

AN - SCOPUS:0023603433

VL - 39

SP - 947

EP - 950

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 11

ER -